Sponsor hub

Indiana University clinical trial failures

Review 60 stopped clinical trials from Indiana University, including disease areas, phases, and classified stop reasons.

This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 3 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.

Total stopped trials60
Likely biological signals3
Shown below60

Dominant stop reasons

OPERATIONAL
36
OTHER/UNKNOWN
19
REGULATORY
2
SAFETY
2
EFFICACY/FUTILITY
1

Notable sponsors

Indiana University
60

Related phases

Phase II
22
Phase IV
14
Phase I
11
Unknown
8
Phase III
5

Crawlable stopped-trial records

Open Explore

Showing up to 60 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.

NCT05312008: Does Oxytocin Alter Tolerance to or Motivation for Alcohol

Phase II Alcohol Use Disorder trial by Indiana University. Stop reason: OTHER/UNKNOWN.

Due to complications delaying the availability of the intranasal oxytocin and IV alcohol solutions needed for this project, we were unable to complete subjects in the self-administration arm of this study.

NCT01974700: Seizure Prophylaxis in Aneurysm Repair

Phase IV Intracranial Aneurysms trial by Indiana University. Stop reason: OPERATIONAL.

Lack of enrollment - since the start of the study in 2013, only 17 subjects have consented. Of those, only 8 completed the study.